RITUXIMAB Safety Questions, RITUXIMAB Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about RITUXIMAB. Our extensive database of RITUXIMAB adverse events and RITUXIMAB warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about RITUXIMAB
RITUXIMAB Safety Reports
Total RITUXIMAB reports: 398.RITUXIMAB FDA safety alerts: 2004 2006 .
Reported deaths: 76 Reported hospitalizations: 240.
Take RITUXIMAB Side Effects Survey or Share Your RITUXIMAB Story. Read More Here.
Showing 1-75 of 398 Next >
Physician from UNITED KINGDOM reported RITUXIMAB problem on May 10, 2007. Female patient, weighting 98.77 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: septic shock. RITUXIMAB dosage: 600 MG, Q28D. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, INSULIN RETARD LEO, FLUKONAZOL. Patient died on 05/01/2007.RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on May 10, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: oesophageal candidiasis. RITUXIMAB dosage: 600 MG, Q28D. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, INSULIN RETARD LEO, SEPTRA, PAROXETINE, FORTASEC. Patient was hospitalized. Patient recovered.
Physician from ITALY reported RITUXIMAB problem on May 04, 2007. Female patient, weighting 127.9 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: overdose. RITUXIMAB dosage: 375 MG, UNK. Patient recovered.
RITUXIMAB problem was reported by a Physician from GERMANY on May 08, 2007. Female patient, weighting 165.3 lb, was diagnosed with rheumatoid arthritis, osteoporosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, multi-organ failure, pleural effusion, pneumonia, staphylococcal sepsis. RITUXIMAB dosage: 1000 MG, SINGLE. During the same period patient was treated with INFLIXIMAB, METHOTREXATE, MELYSDON, TERIPARATIDE, CALCIUM D, MOBLOC, RAMIPRIL. Patient was hospitalized. Patient died on 04/21/2007.
Health Professional from FRANCE reported RITUXIMAB problem on May 11, 2007. Male patient was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cerebral haematoma, paranoia, status epilepticus. RITUXIMAB dosage: 575 MG/M2, UNK. During the same period patient was treated with CORTANCYL, ENDOXAN, FARMARUBICINE, ELDISINE, METHOTREXATE, RIMIFON. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on May 11, 2007. Female patient, weighting 149.9 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cough, cryptogenic organising pneumonia. RITUXIMAB dosage: 1000 MG, QD. During the same period patient was treated with FOSAMAX, CORTANCYL, METHOTREXATE, SPECIAFOLDINE. Patient recovered.
Physician from GERMANY reported RITUXIMAB problem on May 11, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: condition aggravated. RITUXIMAB dosage: 660 MG, SINGLE. During the same period patient was treated with BENDAMUSTINE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED STATES on May 10, 2007. Male patient, 29 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: leukoencephalopathy. RITUXIMAB dosage: 10 MG, 1/WEEK, WK 1. During the same period patient was treated with GLUCOCORTICOIDS, ACETAMINOPHEN, DIPHENHYDRAMINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RITUXIMAB problem on May 23, 2007. Female patient was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. RITUXIMAB dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Pharmacist from UNITED STATES on May 21, 2007. Male patient, weighting 218.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: back pain, hypotension, pruritus, syncope, tachycardia. RITUXIMAB dosage: 935 MG ONCE IV. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXIMAB problem on May 17, 2007. Female patient, weighting 99.21 lb, was diagnosed with systemic lupus erythematosus, gastritis, osteoporosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: myelitis transverse. RITUXIMAB dosage: 1000 MG, 1/WEEK. During the same period patient was treated with ACETAMINOPHEN, POLARAMINE, SAXIZON, NIZATIDINE, CALCIUM CHLORIDE. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Female patient, weighting 114.2 lb, was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: asthenia, atelectasis, breath sounds abnormal, confusional state, delirium, pyrexia, respiratory distress, wheezing. RITUXIMAB dosage: 1156 MG. Patient recovered.
Physician from UNITED STATES reported RITUXIMAB problem on May 18, 2007. Female patient, weighting 160.3 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: chest discomfort. RITUXIMAB dosage: 1000 MG, UNK. During the same period patient was treated with PREDNISONE, PLAVIX, CRESTOR, SINGULAIR, ASPIRIN, SEREVENT, COMBIVENT. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2007. Female patient, 20 years of age, was diagnosed with lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. RITUXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXIMAB problem on May 17, 2007. Female patient was diagnosed with systemic lupus erythematosus and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. RITUXIMAB dosage: 1000 MG/BODY 2 TIMES. Patient died on 03/24/2007.
RITUXIMAB problem was reported by a Health Professional from UNITED STATES on Jan 08, 2007. Female patient, weighting 205.0 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: refusal of treatment by patient, rheumatoid arthritis. RITUXIMAB dosage: 1000 MG, X2. During the same period patient was treated with ACETAMINOPHEN, IBUPROFEN, FOLIC ACID, METHOTREXATE, ALESSE, SLOW FE, NAPROXEN. Patient recovered.
Physician from JAPAN reported RITUXIMAB problem on May 17, 2007. Female patient was diagnosed with systemic lupus erythematosus and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: systemic lupus erythematosus. RITUXIMAB dosage: 1000 MG/BODY. During the same period patient was treated with IMMUNOSUPPRESSANT NOS. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on May 24, 2007. Male patient was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, coronary artery disease, pneumonia cytomegaloviral. RITUXIMAB dosage: 375 MG/M2, X4. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISOLONE, DILTIAZEM, ISOSORBIDE MONONITRATE, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient died on 12/26/2006.
Physician from JAPAN reported RITUXIMAB problem on May 17, 2007. Female patient, weighting 99.21 lb, was diagnosed with systemic lupus erythematosus, gastritis, osteoporosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: myelitis transverse. RITUXIMAB dosage: 1000 MG, 1/WEEK. During the same period patient was treated with ACETAMINOPHEN, POLARAMINE, SAXIZON, NIZATIDINE, CALCIUM CHLORIDE. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 23, 2007. Female patient, weighting 154.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: neuropathy. RITUXIMAB dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, COTRIMOXAZOLE, VALACYCLOVIR. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported RITUXIMAB problem on May 22, 2007. Female patient, weighting 198.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, septic shock. RITUXIMAB dosage: unknown. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, 69 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, intestinal perforation, white blood cell count decreased. RITUXIMAB dosage: 825MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, VINCRISTINE, ASPIRIN, GLUCOSAMINE, CALCIUM CHLORIDE, TOLTERODINE, ENALAPRIL MALEATE. Patient recovered.
Physician from JAPAN reported RITUXIMAB problem on May 25, 2007. Male patient, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma, anaemia, hepatic cirrhosis, prophylaxis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, tumour lysis syndrome. RITUXIMAB dosage: 375 MG, QD. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from FRANCE on May 29, 2007. Male patient, weighting 140.0 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, leukopenia, sinusitis. RITUXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, PARACETAMOL, CETIRIZINE, VINCRISTINE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXIMAB problem on May 24, 2007. Male patient was diagnosed with systemic lupus erythematosus and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: hypogammaglobulinaemia. RITUXIMAB dosage: 200 MG, QD. During the same period patient was treated with CELLCEPT, AZATHIOPRINE, ENDOXAN, DIAMOX, PREDNISOLONE, BAKTAR. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Female patient, weighting 264.6 lb, was diagnosed with systemic lupus erythematosus and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: lupus nephritis. RITUXIMAB dosage: unknown. During the same period patient was treated with PREDNISONE, CELLCEPT, IMURAN. Patient recovered.
Physician from GERMANY reported RITUXIMAB problem on May 23, 2007. Female patient, weighting 165.3 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: disseminated tuberculosis. RITUXIMAB dosage: 1000 MG, UNK. During the same period patient was treated with HUMIRA, ARAVA. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from NEW ZEALAND on May 23, 2007. Male patient was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic steatosis, transaminases increased. RITUXIMAB dosage: 750 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient recovered.
Physician from UNITED KINGDOM reported RITUXIMAB problem on May 25, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. RITUXIMAB dosage: 730 MG, UNK. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, NEUPOGEN. Patient was hospitalized. Patient died on 05/04/2007.
RITUXIMAB problem was reported by a Physician from JAPAN on May 25, 2007. Male patient, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: gastric cancer. RITUXIMAB dosage: 375 MG, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, BIOFERMIN, CYANOCOBALAMIN, RILMAZAFONE HYDROCHLORIDE, AMLODIPINE BESYLATE, SENNA LEAF, SUCRALFATE, ETIZOLAM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RITUXIMAB problem on May 25, 2007. Female patient, child 4 years of age, was diagnosed with opsoclonus myoclonus and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: neuroblastoma. RITUXIMAB dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, CORTICOTROPIN. Patient recovered.
RITUXIMAB problem was reported by a Physician from GERMANY on May 23, 2007. Female patient, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. RITUXIMAB dosage: 375 MG, Q4W. During the same period patient was treated with BENDAMUSTINE, ASPIRIN, ENALAPRIL MALEATE, SIMVASTATIN, CARBAMAZEPINE, TORSEMIDE, DAFALGAN, CLEXANE. Patient died on 12/21/2006.
Physician from GERMANY reported RITUXIMAB problem on May 30, 2007. Female patient, weighting 149.9 lb, was diagnosed with rheumatoid arthritis, osteoporosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: deafness. RITUXIMAB dosage: 1000 MG, UNK. During the same period patient was treated with METHOTREXATE, ARCOXIA, CALCIMAGON. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from FRANCE on May 31, 2007. Female patient was diagnosed with burkitt's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, cardiac failure. RITUXIMAB dosage: 375 MG/M2, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN. Patient died on 05/28/2007.
Health Professional from UNITED STATES reported RITUXIMAB problem on June 05, 2007. Male patient, weighting 180.6 lb, was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, adverse event, myelodysplastic syndrome, no therapeutic response. RITUXIMAB dosage: 375 MG/M2 Q 6 MONTHS X 4 IV. Patient died on 05/18/2007.
RITUXIMAB problem was reported by a Pharmacist from UNITED STATES on June 07, 2007. Female patient, 51 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: chills, dyspnoea, infusion related reaction, no therapeutic response, oxygen saturation decreased, wheezing. RITUXIMAB dosage: 375MG/M2 ONCE IV DRIP. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported RITUXIMAB problem on May 28, 2007. Male patient, weighting 181.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. RITUXIMAB dosage: UNK MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient died on 04/20/2007.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Female patient, 84 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. RITUXIMAB dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, PANTOPRAZOLE, AMLODIPINE, CLONAZEPAM, ACYCLOVIR. Patient recovered.
Physician from ITALY reported RITUXIMAB problem on June 01, 2007. Male patient, weighting 196.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. RITUXIMAB dosage: 770 MG, Q2M. During the same period patient was treated with WARFARIN, ALLOPURINOL. Patient died on 05/17/2007.
RITUXIMAB problem was reported by a Physician from UNITED STATES on June 04, 2007. Female patient, weighting 188.7 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: infusion related reaction. RITUXIMAB dosage: 1000 MG, DAYS 1+15. During the same period patient was treated with TETANUS TOXOID, PNEUMOCOCCAL POLYSACCHARIDE VACCINE, KEYHOLE LIMPET HEMOCYANIN, CANDIDA ALBICANS SKIN TEST. Patient recovered.
Physician from UNITED KINGDOM reported RITUXIMAB problem on June 01, 2007. Male patient was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: embolic stroke. RITUXIMAB dosage: 375 MG/M2, X3. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, 67 years of age, weighting 165.3 lb, was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, thrombocytopenia. RITUXIMAB dosage: 700 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient recovered.
Physician from ITALY reported RITUXIMAB problem on June 12, 2007. Male patient, weighting 196.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. RITUXIMAB dosage: 770 MG, Q2M. During the same period patient was treated with WARFARIN, ALLOPURINOL. Patient died on 05/17/2007.
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on June 08, 2007. Female patient, weighting 198.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, septic shock. RITUXIMAB dosage: 750 MG, UNK. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported RITUXIMAB problem on June 12, 2007. Female patient, weighting 145.5 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, chills, infusion related reaction. RITUXIMAB dosage: 630 MG IV. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Male patient, 80 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cryoglobulinaemia, renal failure. RITUXIMAB dosage: 375 MG/M2, 1/WEEK. Patient recovered.
Physician from UNITED KINGDOM reported RITUXIMAB problem on June 04, 2007. Female patient, weighting 114.6 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: lymphadenopathy. RITUXIMAB dosage: 1000 MG, UNK. During the same period patient was treated with METHOTREXATE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on June 08, 2007. Female patient, weighting 149.9 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia. RITUXIMAB dosage: 1000 MG, QD. During the same period patient was treated with FOSAMAX, CORTANCYL, METHOTREXATE, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXIMAB problem on June 12, 2007. Male patient, 65 years of age, weighting 122.4 lb, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii stage ii and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: abdominal distension, anorexia, gastric cancer, gastritis erosive, lymphocyte count decreased, stomach discomfort. RITUXIMAB dosage: 375 MG/M2, 1X/DAY. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED STATES on June 11, 2007. Female patient, 79 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: mononeuropathy multiplex. RITUXIMAB dosage: 375 MG/M2, UNK. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported RITUXIMAB problem on June 12, 2007. Female patient, weighting 20.06 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. RITUXIMAB dosage: 375 MG/M2, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FILGRASTIM, ACYCLOVIR, COTRIMOXAZOLE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from AUSTRALIA on June 08, 2007. Male patient, 55 years of age, was diagnosed with vasculitis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: chest pain. RITUXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported RITUXIMAB problem on June 08, 2007. Male patient was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: pneumonia cytomegaloviral. RITUXIMAB dosage: 375 MG/M2, X4. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISOLONE, DILTIAZEM, ISOSORBIDE MONONITRATE, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient died on 12/26/2006.
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on June 08, 2007. Female patient, weighting 125.2 lb, was diagnosed with vasculitis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: pneumonia, pulmonary embolism. RITUXIMAB dosage: 562 MG, 1/WEEK. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE, ADCAL, AMPHOTERICIN B LOZENGES, DIGOXIN, FUROSEMIDE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Physician from FINLAND reported RITUXIMAB problem on June 07, 2007. Male patient, weighting 149.9 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: urinary retention. RITUXIMAB dosage: 690 MG, UNK. During the same period patient was treated with PREDNISONE, VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PARACETAMOL, CETIRIZINE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from FRANCE on June 13, 2007. Male patient, weighting 189.6 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. RITUXIMAB dosage: 750 MG, Q3W. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported RITUXIMAB problem on June 14, 2007. Male patient, weighting 165.3 lb, was diagnosed with b-cell lymphoma, prophylaxis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: hepatitis. RITUXIMAB dosage: 652 MG, QD. During the same period patient was treated with PARACETAMOL, SEPTRA, OMEPRAZOLE. Patient recovered.
RITUXIMAB problem was reported by a Physician from GERMANY on June 11, 2007. Female patient, weighting 165.3 lb, was diagnosed with rheumatoid arthritis, osteoporosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, multi-organ failure, pleural effusion, pneumonia, staphylococcal sepsis. RITUXIMAB dosage: 1000 MG, SINGLE. During the same period patient was treated with INFLIXIMAB, METHOTREXATE, TERIPARATIDE, CALCIUM D, FOLCUR, METYSOLON, FORTEO. Patient was hospitalized. Patient died on 04/21/2007.
Consumer or non-health professional from UNITED KINGDOM reported RITUXIMAB problem on June 15, 2007. Female patient, weighting 150.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: delirium, pneumocystis jiroveci infection, pneumonia. RITUXIMAB dosage: 890 MG, X3. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, PANTOPRAZOLE, ASPIRIN, MOCLOBEMIDE, PROVERA, TEMAZEPAM. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from BELGIUM on June 11, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal disorder. RITUXIMAB dosage: 1000 MG, DAYS 1+15. During the same period patient was treated with METHYLPREDNISOLONE, PREDNISONE, METHOTREXATE, FOLIC ACID, DAFALGAN CODEINE, IDOMETHINE. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported RITUXIMAB problem on June 11, 2007. Female patient, 48 years of age, was diagnosed with systemic lupus erythematosus and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia, white blood cell count decreased. RITUXIMAB dosage: 375 MG/M2, UNK. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED STATES on June 12, 2007. Male patient, weighting 196.0 lb, was diagnosed with multiple sclerosis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute. RITUXIMAB dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported RITUXIMAB problem on June 14, 2007. Female patient, weighting 185.2 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary tuberculosis. RITUXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, MITOXANTRONE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on June 15, 2007. Female patient, weighting 172.8 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. RITUXIMAB dosage: 1000 MG, UNK. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported RITUXIMAB problem on June 14, 2007. Female patient, weighting 185.2 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary tuberculosis. RITUXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, MITOXANTRONE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 15, 2007. Female patient, weighting 154.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: neuropathy. RITUXIMAB dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, COTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported RITUXIMAB problem on June 04, 2007. Female patient, weighting 114.6 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: lymphadenopathy. RITUXIMAB dosage: 1000 MG, UNK. During the same period patient was treated with METHOTREXATE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED STATES on June 19, 2007. Female patient, weighting 188.7 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: infusion related reaction. RITUXIMAB dosage: 1000 MG, DAYS 1+15. During the same period patient was treated with TETANUS TOXOID, PNEUMOCOCCAL POLYSACCHARIDE VACCINE, KEYHOLE LIMPET HEMOCYANIN, CANDIDA ALBICANS SKIN TEST. Patient recovered.
Physician from GERMANY reported RITUXIMAB problem on June 07, 2007. Female patient, weighting 165.3 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: disseminated tuberculosis. RITUXIMAB dosage: 1000 MG, UNK. During the same period patient was treated with HUMIRA, ARAVA, STEROIDS NOS, TAVEGIL. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from UNITED STATES on June 20, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: breast cancer. RITUXIMAB dosage: 1000 MG, DAYS 1+15. During the same period patient was treated with METHYLPREDNISOLONE, PREDNISONE, FOLIC ACID, INSULIN, MONOPRIL, ROSIGLITAZONE, METHOTREXATE, HYDROXYCHLOROQUINE SULPHATE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported RITUXIMAB problem on June 13, 2007. Male patient, weighting 189.6 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. RITUXIMAB dosage: 750 MG, Q3W. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient was hospitalized. Patient recovered.
RITUXIMAB problem was reported by a Physician from JAPAN on June 22, 2007. Male patient, 65 years of age, weighting 122.4 lb, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii stage ii and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: gastric cancer. RITUXIMAB dosage: 375 MG/M2, 1X/DAY. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported RITUXIMAB problem on June 22, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection. RITUXIMAB dosage: 50 MG/M2, UNK. During the same period patient was treated with FLUDARA, CAMPATH, BENADRYL, ACETAMINOPHEN, COTRIM. Patient died on 01/01/2007.
RITUXIMAB problem was reported by a Physician from SPAIN on June 25, 2007. Male patient, weighting 165.3 lb, was diagnosed with b-cell lymphoma, prophylaxis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: hepatitis b. RITUXIMAB dosage: 652 MG, QD. During the same period patient was treated with ACETAMINOPHEN, SEPTRA, OMEPRAZOLE. Patient recovered.
Pharmacist from UNITED STATES reported RITUXIMAB problem on June 21, 2007. Female patient was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, myelodysplastic syndrome. RITUXIMAB dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with ACETAMINOPHEN, DIPHENHYDRAMINE, HYDROCORTISONE. Patient recovered.
Showing 1-75 of 398 Next >
This
drug has an active FDA Safety Alert